Results 81 to 90 of about 2,606,922 (264)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations

Discover Oncology
Oncolytic Virus (OVs) is an emerging approach to tumour immunity that allows the use of natural or genetically modified viruses to specifically infect and lyse tumour cells without damaging normal cells.
Xuejiao Qi
doaj   +1 more source

Results of A Local Combination Therapy Antibiogram For \u3cem\u3ePseudomonas Aeruginosa\u3c/em\u3e Isolates: Is Double Worth The Trouble? [PDF]

, 2017
Purpose: To determine the frequency at which fluoroquinolones and aminoglycosides demonstrate in vitro activity against non-urinary, non-skin/skin structure Pseudomonas aeruginosa isolates exhibiting decreased susceptibilities to one or more β-lactam ...
Davis, Jim, Dilworth, Thomas J., Elshaboury, Ramy, Munson, Erik, Song, Matthew   +4 more
core   +1 more source

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future [PDF]

, 2019
In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative treatment options are no ...
Amthauer, Holger, Jann, Henning, Kayser, Antonin, Roderburg, Christoph, Stueven, Anna Kathrin, Tacke, Frank, Wetz, Christoph, Wiedenmann, Bertram, Wree, Alexander   +8 more
core   +1 more source

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies. [PDF]

, 2017
PURPOSE/OBJECTIVES: Radium-223 is a first-in-class radiopharmaceutical recently approved for the treatment of castration-resistant prostate cancer in patients with symptomatic bone metastases.
Basch, Beer, Chen, Cookson, De Bono, Den, Dreicer, Fizazi, Hoskin, Kantoff, Keizman, Morris, Nilsson, Nilsson, Parker, Petrylak, Ryan, Scher, Siegel, Tannock, Tu   +20 more
core   +2 more sources

Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy

Frontiers in Immunology, 2018
Immune checkpoint inhibitors (ICIs) have recently revolutionized cancer treatment, providing unprecedented clinical benefits. However, primary or acquired therapy resistance can affect up to two-thirds of patients receiving ICIs, underscoring the urgency
Yiyi Yan, Anagha Bangalore Kumar, Heidi Finnes, Svetomir N. Markovic, Sean Park, Roxana S. Dronca, Haidong Dong, Haidong Dong   +7 more
doaj   +1 more source

Serum and Vaccine Therapy in Combination with Sulphanilamide or M and B 693 [PDF]

, 1939
Alexander Fleming
openalex   +1 more source

Successful transition from Treprostinil to Selexipag in patient with severe pulmonary arterial hypertension

BMC Pulmonary Medicine, 2017
Background In this report, we describe the first successful case of transition from subcutaneous administration of treprostinil to selexipag in a patient with severe pulmonary arterial hypertension (PAH), by evaluating hemodynamic changes and exercise ...
Asuka Furukawa, Yuichi Tamura, Hiroya Iwahori, Masato Goto, Narutaka Ohashi, Teruo Okabe, Akio Kawamura   +6 more
doaj   +1 more source

Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and Methotrexate [PDF]

, 1961
Emil Frei, Emil J. Freireich, Edmund A. Gehan, Donald Pinkel, James F. Holland, Oleg S. Selawry, Farid I. Haurani, Charles L. Spurr, Donald M. Hayes, G. Watson James, Harvey Rothberg, D. Bruce Sodee, R. Wayne Rundles, LESLIE R. SCHROEDER, Barth Hoogstraten, Irving J. Wolman, Demetrius Traggis, Talbert Cooper, Benjamin R. Gendel, Franklin G. Ebaugh, Robert Taylor   +20 more
openalex   +1 more source

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin

Diabetes, Metabolic Syndrome and Obesity, 2016
Stanley S Schwartz,1,2 Arie Katz3 1University of Pennsylvania, Philadelphia, PA, USA; 2Main Line Health System, Ardmore, PA, USA; 3AstraZeneca, Fort Washington, PA, USA Abstract: In type 2 diabetes (T2D), early combination therapy using agents that ...
Schwartz SS, Katz A
doaj  

Recent progresses in combination cancer therapy using cyanine dye-based nanoparticles

Pharmaceutical Science Advances
Surgical resection, radiotherapy, and chemotherapy are traditional methods for cancer treatment. With the development of materials science, photodynamic, photothermal, and sonodynamic therapies have been established over the past few years. Despite these
Qian An, Si-Rui Xiang, You-Quan Zou
doaj   +1 more source